Browsing Tag
BriaCell Therapeutics
4 posts
FDA opens first human test for BriaCell’s prostate cancer cell therapy
Bria-PROS+ gains FDA clearance for its first prostate cancer trial, expanding BriaCell’s off-the-shelf cellular immunotherapy platform.
Breakthrough in breast cancer treatment? BriaCell Therapeutics shares soar 150%!
BriaCell Therapeutics Corp., a clinical-stage biotechnology company, saw its shares surge by more than 150% to $1.55 following…
BriaCell Therapeutics gets license for anti-cancer agent sCD80 from UMBC
BriaCell Therapeutics has signed an exclusive licensing deal with the University of Maryland, Baltimore County (UMBC) to develop…
BriaCell Therapeutics’ Bria-IMT gets FDA fast track status in breast cancer
BriaCell Therapeutics has secured the fast track status from the US Food and Drug Administration (FDA) for its…